ANDA 77024, held by Hikma. Cilostazol.
As of Nov 16, 2026, ANDA 77024 (Cilostazol), held by Hikma, was first approved by FDA on May 17, 2005, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 2005 | Original application | Approved | None posted |
| Cilostazol50MG · tablet;oral | Cilostazol | Discontinued |
| Cilostazol100MG · tablet;oral | Cilostazol | Discontinued |
| Mar 25, 2016 | Supplement 7Labeling · Standard review | Approved | None posted |
| Mar 25, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Sep 9, 2008 | Supplement 2Labeling | Approved | None posted |
| Jul 9, 2008 | Supplement 1Labeling | Approved | None posted |
| May 17, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters